Novonesis (novozymes)-ADRNVZMY
13F holders, Q1 2026 (March 31)10holders −1
3new positions
4sold out
$59.56avg. 13F price*
At the end of Q1 2026, 10 institutions reported holding Novonesis (novozymes)-ADR (NVZMY) in their 13F filings, down 1 from Q4 2025. 3 opened new positions and 4 sold out. The largest holders were Rhumbline Advisers ($602K), S&co Inc. ($265K) and Alta Capital Management LLC/ ($231K).
- Company
- Novonesis (novozymes)-ADR
- Filed as
- NOVOZYMES A/S-UNSPONS ADR (Q1 2026)
- CUSIP
- 670108109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $233K |
| Exits | 4 | $16K |
All 13F filers, Q4 2025 → Q1 2026: 3,960 shares bought and 7,922 shares sold, net −3,962 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| Rhumbline Advisers | 0.00% | Add +0.6% | 10,073 | $602K |
| S&co Inc. | 0.02% | No change | 4,500 | $265K |
| Alta Capital Management LLC/ | 0.02% | New | 3,859 | $231K |
| GAMMA Investing LLC | 0.00% | Reduce -33.5% | 1,513 | $90K |
| Sterling Capital Management LLC | 0.00% | Reduce -97.2% | 150 | $9K |
| Salomon & Ludwin, LLC | 0.00% | Reduce -75.1% | 59 | $4K |
| Lanark Financial, Inc. | 0.00% | New | 40 | $2K |
| PNC Financial Services Group, Inc. | 0.00% | Reduce -98.7% | 21 | $1K |
| IMA Advisory Services, Inc. | 0.00% | Reduce -13.3% | 13 | $782 |
| Hanson & Doremus Investment Management | 0.00% | New | 1 | $0 |
"% of holder's portfolio" is NVZMY's weight in each manager's 13F, not the share of Novonesis (novozymes)-ADR the manager owns.